We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
TIDMGSK
RNS Number : 8593B
GlaxoSmithKline PLC
15 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms E Walmsley === ====================== ================================= b) Position/status Chief Executive Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 17 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr R G Connor === ====================== ================================= b) Position/status President, Global Manufacturing & Supply === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 67 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr S Dingemans === ====================== ================================= b) Position/status Chief Financial Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 23 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr N Hirons === ====================== ================================= b) Position/status SVP, Global Ethics & Compliance === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 10 ------------ ---------- === ====================== =================================
d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr D S Redfern === ====================== ================================= b) Position/status Chief Strategy Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 76 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms C Thomas === ====================== ================================= b) Position/status SVP, Human Resources === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 76 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr P C Thomson === ====================== ================================= b) Position/status President, Global Affairs === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 42 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Dr P J T Vallance === ====================== ================================= b) Position/status President, R&D === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ---------- GBP13.3087 47 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mrs V A Whyte === ====================== ================================= b) Position/status Company Secretary === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018, on shares held through the Company's Share Reward Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP13.3087 54 ------------ ---------- === ====================== ================================= d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== =================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKELBFVFFFBBQ
(END) Dow Jones Newswires
January 15, 2018 04:18 ET (09:18 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions